163 related articles for article (PubMed ID: 34016482)
1. Diagnosis and Prevalence of Cirrhotic Cardiomyopathy: A Systematic Review and Meta-analysis.
Shahvaran SA; Menyhárt O; Csedrik L; Patai ÁV
Curr Probl Cardiol; 2021 Oct; 46(10):100821. PubMed ID: 34016482
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.
Kapoor N; Mehta V; Singh B; Karna R; Kumar S; Kar P
Indian J Gastroenterol; 2020 Oct; 39(5):481-486. PubMed ID: 33188455
[TBL] [Abstract][Full Text] [Related]
3. Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy.
Abbas WA; Kasem Ahmed SM; Abdel Aal AM; Mahmoud AA; Abdelmalek MO; Mekky MA; Abozaid MA; Ibrahim AK
Turk J Gastroenterol; 2016 Jul; 27(4):367-74. PubMed ID: 27458853
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.
Bokarvadia R; Jain M; Kedarisetty C; Varghese J; Venkataraman J
Indian J Gastroenterol; 2019 Apr; 38(2):150-157. PubMed ID: 31115783
[TBL] [Abstract][Full Text] [Related]
5. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.
Sampaio F; Pimenta J; Bettencourt N; Fontes-Carvalho R; Silva AP; Valente J; Bettencourt P; Fraga J; Gama V
Liver Int; 2013 Sep; 33(8):1158-65. PubMed ID: 23617332
[TBL] [Abstract][Full Text] [Related]
6. New Definition Criteria of Myocardial Dysfunction in Patients with Liver Cirrhosis: A Speckle Tracking and Tissue Doppler Imaging Study.
Rimbaş RC; Baldea SM; Guerra RDGA; Visoiu SI; Rimbaş M; Pop CS; Vinereanu D
Ultrasound Med Biol; 2018 Mar; 44(3):562-574. PubMed ID: 29306590
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular function is related with amphiregulin and fibrosis markers in cirrhotic cardiomyopathy.
Grzebyk E; Pazgan-Simon M; Jagas J; Zuwala-Jagiello J; Gorka-Dynysiewicz J
J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793762
[TBL] [Abstract][Full Text] [Related]
8. Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria.
Izzy M; Soldatova A; Sun X; Angirekula M; Mara K; Lin G; Watt KD
Liver Transpl; 2021 Jun; 27(6):876-886. PubMed ID: 33533556
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome.
Anikhindi SA; Ranjan P; Kumar M; Mohan R
J Clin Exp Hepatol; 2022; 12(3):853-860. PubMed ID: 35677509
[TBL] [Abstract][Full Text] [Related]
10. Cardiac time intervals by tissue Doppler imaging M-mode echocardiography: reproducibility, reference values, association with clinical characteristics and prognostic implications.
Biering-Sørensen T
Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477801
[TBL] [Abstract][Full Text] [Related]
11. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia.
Karagiannakis DS; Vlachogiannakos J; Anastasiadis G; Vafiadis-Zouboulis I; Ladas SD
Dig Dis Sci; 2013 Oct; 58(10):3029-36. PubMed ID: 23907333
[TBL] [Abstract][Full Text] [Related]
12. Current Concepts of Cirrhotic Cardiomyopathy.
Izzy MJ; VanWagner LB
Clin Liver Dis; 2021 May; 25(2):471-481. PubMed ID: 33838862
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the 2005 Montreal Criteria and the 2019 Cirrhotic Cardiomyopathy Consortium Criteria for the Diagnosis of Cirrhotic Cardiomyopathy.
Luo Y; Yin S; Chen Q; Liu J; Chong Y; Zhong J
Am J Cardiol; 2023 Dec; 208():180-189. PubMed ID: 37852128
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria.
Razpotnik M; Bota S; Wimmer P; Hackl M; Lesnik G; Alber H; Peck-Radosavljevic M
Liver Int; 2021 May; 41(5):1058-1069. PubMed ID: 33342074
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular function assessment in cirrhosis: Current methods and future directions.
Sampaio F; Pimenta J
World J Gastroenterol; 2016 Jan; 22(1):112-25. PubMed ID: 26755864
[TBL] [Abstract][Full Text] [Related]
16. [Left ventricular functions in patients with cardiac syndrome X: a tissue Doppler study].
Yazici HU; Sen N; Tavil Y; Hizal F; Turfan M; Poyraz F; Boyaci B; Cengel A
Anadolu Kardiyol Derg; 2009 Dec; 9(6):467-72. PubMed ID: 19965317
[TBL] [Abstract][Full Text] [Related]
17. Cirrhotic cardiomyopathy.
Elleuch N; Mrabet S; Ben Slama A; Jaziri H; Hammami A; Brahim A; Ajmi S; Ksiaa M; Jmaa A
Tunis Med; 2020 Mar; 98(3):206-210. PubMed ID: 32395813
[TBL] [Abstract][Full Text] [Related]
18. Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome.
Pouriki S; Alexopoulou A; Chrysochoou C; Raftopoulos L; Papatheodoridis G; Stefanadis C; Pectasides D
Liver Int; 2011 Oct; 31(9):1388-94. PubMed ID: 21771264
[TBL] [Abstract][Full Text] [Related]
19. Review article: comprehensive analysis of cirrhotic cardiomyopathy.
Chahal D; Liu H; Shamatutu C; Sidhu H; Lee SS; Marquez V
Aliment Pharmacol Ther; 2021 May; 53(9):985-998. PubMed ID: 33689169
[TBL] [Abstract][Full Text] [Related]
20. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.
Kazankov K; Holland-Fischer P; Andersen NH; Torp P; Sloth E; Aagaard NK; Vilstrup H
Liver Int; 2011 Apr; 31(4):534-40. PubMed ID: 21382164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
